Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC) Share Price

Price 107.00p on 11-08-2026 at 18:25:08
Change -0.80p -0.74%
Buy 108.00p
Sell 107.00p
Last Trade: Unknown 67,615.00 at 107.00p
Day's Volume: 190,551
Last Close: 107.00p
Open: 107.80p
ISIN: GG00B8P59C08
Day's Range 107.00p - 108.00p
52wk Range: 86.90p - 109.80p
Market Capitalisation: £650.78m
VWAP: 107.28488p
Shares in Issue: 608.20m

Syncona (SYNC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 67,615 107.00p Uncrossing Trade
16:35:13 - 11-Aug-26
Buy* 848 108.00p SI Trade
16:28:31 - 11-Aug-26
Sell* 2,589 107.00p SI Trade
15:55:47 - 11-Aug-26
Buy* 3 107.648p Ordinary
15:15:32 - 11-Aug-26
Buy* 2,700 108.00p Ordinary
14:46:44 - 11-Aug-26
Sell* 2,803 107.00p Automatic Execution
14:45:54 - 11-Aug-26
Buy* 46 107.648p Ordinary
14:31:48 - 11-Aug-26
Sell* 930 107.436p Negotiated Trade
13:15:54 - 11-Aug-26
Buy* 46 107.649p Ordinary
13:15:53 - 11-Aug-26
Buy* 97 107.65p Ordinary
13:15:53 - 11-Aug-26
See more Syncona trades

Syncona (SYNC) Share Price History

Time period:
to
Date Open High Low Close Volume
10th Aug 2026 (Mon) 109.40 109.40 107.00 107.80 984,169
7th Aug 2026 (Fri) 109.00 109.00 108.00 108.60 329,693
6th Aug 2026 (Thu) 105.00 108.60 105.00 108.60 2,854,212
5th Aug 2026 (Wed) 105.00 106.80 105.00 106.00 458,847
4th Aug 2026 (Tue) 105.60 107.00 105.60 106.60 466,090
3rd Aug 2026 (Mon) 108.00 108.00 105.60 106.80 110,919
31st Jul 2026 (Fri) 106.40 107.00 106.00 106.40 1,594,056
30th Jul 2026 (Thu) 105.00 107.00 105.00 106.00 266,329
29th Jul 2026 (Wed) 105.00 107.00 105.00 107.00 609,126
28th Jul 2026 (Tue) 108.00 108.00 105.00 105.40 992,212
27th Jul 2026 (Mon) 105.60 108.00 105.60 107.80 154,601
24th Jul 2026 (Fri) 107.00 107.00 105.60 106.00 130,230
23rd Jul 2026 (Thu) 104.00 107.00 104.00 105.60 307,821
22nd Jul 2026 (Wed) 106.80 107.00 104.40 107.00 153,971
21st Jul 2026 (Tue) 104.00 104.60 104.00 104.20 1,031,565
20th Jul 2026 (Mon) 105.80 107.40 104.00 105.00 142,095
17th Jul 2026 (Fri) 108.80 108.80 106.00 107.00 1,863,619
16th Jul 2026 (Thu) 106.60 107.60 106.00 107.00 466,844
15th Jul 2026 (Wed) 109.00 109.00 106.60 106.80 307,395
14th Jul 2026 (Tue) 106.40 109.00 106.40 106.80 210,354
13th Jul 2026 (Mon) 108.40 108.40 106.40 106.80 3,003,650
See more Syncona price history

Syncona (SYNC) Regulatory News

Date Source Headline
6th Aug 2026 7:00 am RNS First Quarter Update
4th Aug 2026 2:00 pm RNS Holding(s) in Company
3rd Aug 2026 7:00 am RNS Total Voting Rights
30th Jul 2026 2:00 pm RNS Holding(s) in Company
23rd Jul 2026 9:49 am RNS Issue of Shares pursuant to Incentive Scheme
3rd Jul 2026 7:00 am RNS Notice of AGM
3rd Jul 2026 7:00 am RNS Holding(s) in Company
30th Jun 2026 7:00 am RNS Holding(s) in Company
22nd Jun 2026 7:00 am RNS Director/PDMR Shareholding
18th Jun 2026 7:03 am RNS Final Results
See more Syncona regulatory news

Syncona (SYNC) Share News

UK shareholder meetings calendar - next 7 days

11th Aug 2026 13:48

Read More

FTSE 250 EARNINGS & UPDATES: TBC Bank profits from Georgian economy

6th Aug 2026 14:28

(Alliance News) - The following is a round-up of earnings and trading updates by FTSE 250-listed London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Syncona asset value holds steady amid divergent investment returns

18th Jun 2026 10:43

(Alliance News) - Syncona Ltd on Thursday reported a flat annual performance for net asset value, with upside from Beacon Therapeutics PLC offset by write-downs elsewhere. Read More

IN BRIEF: Syncona invests GBP18 million in Beacon financing round

8th Jan 2026 15:45

Syncona Ltd - London-based investor in life science companies - Invests USD24.5 million in ophthalmic gene therapy company Beacon Therapeutics' USD75 million Series C financing. Says the financing round was oversubscribed and brings Beacon's total funding raised so far to approximately USD367 million. Beacon will use the proceeds "to progress commercialisation plans" and to complete the development of its lead programme laru-zova, "a potential best-in-class gene therapy" for X-linked retinitis pigmentosa, Syncona says. Syncona's holding value of Beacon will now be USD237.6 million, including new capital invested, and it will hold a 38.4% ownership stake. Read More

Syncona says positioned for biotech growth after net asset value fall

13th Nov 2025 13:02

(Alliance News) - Syncona Ltd on Thursday reported a fall in its net asset value but said it is well-positioned to deliver value as market conditions in biotech improve. Read More

See more Syncona news
FTSE 100 Latest
Value10,844.19
Change-18.31

Login to your account

Forgot Password?

Not Registered